In the last year, Swiss pharma giant Novartis has spent nearly $15 billion on acquisitions that are pivoting the company toward treatments that bear little resemblance to traditional drugs, according to The Wall Street Journal.
Pharmacy
After pressure from stakeholders, AstraZeneca has started looking for candidates to replace CEO Pascal Soriot, who has served at the helm of the drug company for six years, according to The (UK) Times.
Whether its Amazon's entry into the pharmacy space or changes with the 340B Drug Discount Program, it's no secret that the pharmacy sector is evolving.
Kaleo, a Virginia pharmaceutical company, raised the price of its opioid antidote by more than 600 percent in 2016 to "capitalize on the opportunity" as the nationwide epidemic worsened, according to a report released by a subcommittee chaired by Ohio…
In a bid to raise cash to focus on higher growth areas, Eli Lilly & Co. is mulling a sale of its off-patent drugs in China, according to Bloomberg.
Advertisement
Prescription drug spending makes up over 20 percent, or more than $100 billion, of what Blue Cross Blue Shield spends on its commercially insured members' healthcare, according to the health insurer.
Florida expanded the scope of its original opioid lawsuit to include two pharmacy giants, CVS and Walgreens, according to ABC News.
Despite agreeing to freeze prices in July under heavy pressure from President Donald Trump, Pfizer plans to raise the price of 41 prescription drugs in January, according to The Wall Street Journal.
Bristol-Myers Squibb will lay off 69 employees from its Tampa, Fla.-based facility Jan. 31, according to The Tampa Bay Business Journal.
A U.S. appeals court ruled Nov. 13 that Allergan's patents on its blockbuster eye drug Restasis are invalid, according to Bloomberg.